Member Area

FarmavitaR+ : Regulatory Affairs Network

Saturday
Jan 10th
Home arrow FarmavitaR+ Journal arrow Business News arrow Dendrimers - Drug Delivery to Cancer
Dendrimers - Drug Delivery to Cancer Print E-mail
Written by Dr.(Mrs)Swarnlata Saraf   
Sunday, 16 December 2007
Article Index
Dendrimers - Drug Delivery to Cancer
Page 2
Page 3
Conclusion

The future of dendrimer drug delivery lies is fine tuning the carrier to incorporate variety of drugs and complex protein to ensure the vectorization of dendrimer-complex\conjugates to desired cells\tissues. The major focus will be on development of dendrimer based on new concept of biommetism\biomorphism with plasma stability and capability to target cell in various body compartments. Novel supramolecular structures based on polyethylene oxide copolymers and dendrimers are being intensively researched for delivery of genes and macromolecules. Hydrogels that can respond to a variety of physical, chemical and biological stimuli hold enormous potential for design of closed-loop drug-delivery systems. Design and synthesis of novel combinations of polymers will expand the scope of new drug-delivery systems in the future. 

References

1. Dendrimer in gene delivery Advanced drug delivery review, vol. 57 Dec 2005 page 2177–2202.

2. Immunological application of DNA Dendrimer, Clinical immunology vol. 119 supplements page196.

3. Dendrimer biomedical application –reflection on the field. Advanced drug delivery review, vol. 57 Dec 2005 page 2106–2129.

4. Dendrimers Biocompatibility and toxicity Advanced drug delivery review, vol. 57 Dec 2005 page 2177–2202.

5. Dendrimer and dendritic polymer in drug delivery drug discovery today, vol 10, Jan. 2005, page 35-43.

6. Virus based nanoparticals platform technologies for diagnostic imaging, advanced drug delivery reviews vol. 58 Dec 2006 page 1505- 1572.

7. A to Z Nanotechnology dendrimer definition, dendrimer in medicine, other industry application and examples of product.

8. Synthesis, characterization and stability of dendrimer prodrug, international journal of pharmaceutics, vol. 308,Feb 2006, page 175 –182.

9. In vitro biological evaluation of high molecular weight hyper branched polyglycerol.biomaterials, vol. 28 issue 32 Nov 2007 page no 4797-4787.

10.Biological properties of low molecular mass peptide dendrimer, international journal of pharmaceutics, vol. 309, Feb 2006, page 208-217 .

Comments
Add NewSearchRSS
Zdravko - Great Article   | Administrator | 2008-01-26 19:11:37
avatar Thank you for sharing this great article at Farmavita.Net. Your contribution is very welcomed.

Regards,

Zdravko
Only registered users can write comments!

Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved.

Read also at Pharmaceutical Licensing Network
Related News
Newer news items
Related Items
Farmavita.Net - The Pharmaceutical Licensing Network




Reddit!Del.icio.us!Google!Live!Facebook!Slashdot!Netscape!Technorati!StumbleUpon!Newsvine!Furl!Blogmarks!Yahoo!Ma.gnolia!FeedMeLinks!Free social bookmarking plugins and extensions for Joomla! websites!


Last Updated ( Tuesday, 29 January 2008 )
 
< Prev   Next >
Advertisement

3D Content Cloud

BabelFish Translator




Click Flag for Translation

Sponsors

Member Log-in

Log-in to FarmavitaR+ community & network Membership is FREE!

Who's Online

We have 2 guests online

Subscribe to RSS


Regulatory Affairs

RA Section

Reports

Click to Reports

Events

Click to Events

Groups

Groups